Subscribe

Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Sanofi takes on Mylan over diabetes injection
Americas
Sanofi takes on Mylan over diabetes injection
Sanofi has taken on Mylan in its latest lawsuit over Lantus (insulin glargine injection), which is used to help control the blood sugar level of those with diabetes.   25 October 2017
Biosimilar boom could save billions, think tank claims
Americas
Biosimilar boom could save billions, think tank claims
Introducing more biosimilars could cut healthcare spending by $54 billion over the next ten years, a figure far higher than initially thought, a think tank and research organisation has claimed.   25 October 2017
US politicians concerned over ‘contradictory’ biotech regulatory efforts
Americas
US politicians concerned over ‘contradictory’ biotech regulatory efforts
Nearly 80 members of the House of Representatives have written to the heads of three government departments to voice concerns over regulatory proposals in the biotechnology and gene-editing fields.   24 October 2017
Americas
Native American tribe hits back at Mylan in PTAB filing
The Saint Regis Mohawk Tribe, the owner of dry eye disease treatment Restasis (cyclosporine ophthalmic emulsion), has hit back at Mylan for questioning its sovereign immunity.   24 October 2017
Big Pharma
‘SeboCalm’ mark too similar to ‘Sebotherm’, says General Court
The EU General Court has affirmed a decision that a trademark application for ‘SeboCalm’ is confusingly similar to the earlier word mark ‘Sebotherm’.   23 October 2017
Americas
Generic Restasis plans revealed days after patent invalidation
A San Diego-based company has announced plans to sell a generic version of Allergan’s dry eye disease treatment Restasis (cyclosporine ophthalmic emulsion), just days after four patents covering the drug were invalidated.   23 October 2017
Big Pharma
Alnylam faces declaratory relief claim over SPCs
Alnylam Pharmaceuticals and The Medicines Company UK are facing a claim for declaratory relief over supplementary protection certificates requested by biotech company Silence Therapeutics.   20 October 2017
Big Pharma
CJEU clarifies jurisdiction rules in ‘Merck’ trademark battle
Europe’s highest court has found that in parallel lawsuits dealing with an identical trademark, the first court must take priority over the second—but not in all cases.   19 October 2017
Americas
Amneal and Impax merge to become ‘fifth largest’ generics company
Amneal Pharmaceuticals and Impax Laboratories have agreed to merge, in a deal the companies say will create the fifth largest generics drugs business in the US.   19 October 2017
Americas
Broad and DuPont yield CRISPR licensing deal in agriculture
The Broad Institute of Harvard and MIT has signed a patent licensing deal with DuPont Pioneer to provide CRISPR/Cas9 technology to agricultural researchers and producers.   19 October 2017